Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spleen invigoration, or 'Jianpi,' is a fundamental therapeutic principle in Traditional Chinese Medicine (TCM) rather than a discrete molecular target like a protein or receptor [1]. In TCM theory, the 'Spleen' refers to a functional system responsible for digestion, nutrient absorption, and the distribution of energy (Qi), and its dysfunction leads to 'Spleen Qi Deficiency' characterized by fatigue and digestive distress [2]. Scientific investigations into this concept suggest that spleen-invigorating agents, such as Sijunzi Decoction, work by modulating the gut-microbiota-immune axis and regulating gastrointestinal motility through hormones like gastrin [3]. These agents often contain active compounds like ginsenosides and atractylenolides that exhibit anti-inflammatory and metabolic-regulating properties [4]. From a modern biotech perspective, 'Spleen invigoration' represents a holistic pharmacological effect or clinical outcome rather than a specific druggable molecule, making it 'incorrect' when categorized as a standard therapeutic target [5].
Spleen invigoration involves a multi-target pharmacological approach that modulates gastrointestinal hormones (e.g., gastrin, motilin), restores gut microbiota diversity, enhances the activity of digestive enzymes (e.g., amylase), and regulates the hypothalamic-pituitary-adrenal (HPA) axis to improve metabolic and immune homeostasis.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spleen invigoration.